SMAD5 and breast carcinoma: LncRNA SNHG16/miR-16-5p/SMAD5-regulatory axis potentiates TGF-β1/SMAD5 pathway activation, thus inducing CD73 expression in Vδ1 T cells in breast cancer-derived exosomal (48).